Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firms Still In Dark Over No-Deal Brexit Supply Routes

Executive Summary

Life science companies need more information on plans for alternative medicine supply routes if the UK leaves the EU without a deal, according to the BioIndustry Association, which says the release of the Operation Yellowhammer document shows the “significant impact” such an outcome would have on the sector.

You may also be interested in...

UK Audit Office Warns On No-Deal Brexit Medicines Supply

A lot of work has gone into planning for the impact of a no-deal Brexit on the UK medicines sector, but with only a month to go much remains to be done to ensure the country has the capacity to handle supply chain disruptions, says the National Audit Office.

Industry Still Awaiting Clarity On Brexit Supply Chain Arrangements

As the Brexit clock continues to tick, industry says it is not impressed by government reassurances that all is well where the continued supply of medicines is concerned.

Will Pharma Firms Bear Cost Of UK Govt’s Latest No-Deal Brexit Supply Plans?

Life science companies are uneasy over the government’s latest proposals for emergency medical supplies to the UK if the country leaves the EU without a deal.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts